Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 28, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 727,310	$ 258,770
Marketable securities	0	286,736
Accounts receivable	201,548	69,206
Unbilled accounts receivable	218,233	121,149
Inventories	106,136	136,121
Deferred expenses	1,058	34,577
Prepaid expenses and other current assets	101,252	85,236
Total current assets	1,355,537	991,795
Property and equipment, net	97,109	34,507
Intangible assets, net	3,664	217
Equity method investment	81,289	0
Other assets	40,953	24,191
Total assets	1,578,552	1,050,710
Current liabilities:
Accounts payable	175,188	109,918
Accrued expenses and other current liabilities	165,644	128,314
Deferred revenue	676,314	787,227
Total current liabilities	1,017,146	1,025,459
Deferred revenue	129,233	0
Other liabilities	42,043	27,967
Total liabilities	1,188,422	1,053,426
Commitments and contingencies (Note 17)
Equity:
Additional paid-in capital - warrants	0	58,126
Additional paid-in capital	1,523,692	1,254,022
Accumulated deficit	(1,323,925)	(1,310,435)
Accumulated other comprehensive loss	(2,594)	(1,687)
Total stockholders' equity	197,233	82
Noncontrolling interest	192,897	(2,798)
Total equity	390,130	(2,716)
Total liabilities and equity	1,578,552	1,050,710
Class A Common Stock
Equity:
Common stock, value, issued	13	8
Class V-1 Common Stock
Equity:
Common stock, value, issued	7	7
Class V-3 Common Stock
Equity:
Common stock, value, issued	$ 40	$ 41